Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 2 December 2008, doi:10.1136/bmj.a2824
Cite this as: BMJ 2008;337:a2824
Roger Dobson
1 Abergavenny
| The first 150 words of the full text of this article appear below. |
The drug company Eli Lilly has been found to have breached the UK industrys code of practice by encouraging patients to ask for a prescription only drug.
The company, maker of tadalafil (marketed as Cialis), has been ruled to be in breach of the code of the Association of the British Pharmaceutical Industry, including bringing discredit on and reducing confidence in the industry and failing to maintain high standards.
The ruling says that Eli Lilly breached the code by encouraging patients, through a chart and action plan on a website and a leaflet, to ask their doctor for a specific prescription only drug.
One page of the website contained a table that listed the treatment types available for erectile dysfunction, says the ruling.
The Prescription Medicines Code of Practice Authority, which was set up to operate the code of practice, said, "Product 1 in the list was clearly Cialis. Any
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?